Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine added to etomidate vs etomidate alone for prevention of post-induction hypotension in elderly PKP patients
ChiCTR2500110874Phase 4Not yet recruiting
- Sponsor
- Fourth Affiliated Hospital of Soochow University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in intraoperative hypotension (IOH) and hypotension (2 arms), sponsored by Fourth Affiliated Hospital of Soochow University. Primary endpoint: AUC of change in mean arterial pressure within 15 minutes after general anesthesia induction. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
intraoperative hypotension (IOH)hypotension
Beyond the preview
Go deeper on ChiCTR2500110874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110874.